Fertility and Sterility
Volume 91, Issue 5, Supplement , Pages 2037-2042 , May 2009

Effect of a phosphodiesterase type 3 inhibitor in oocyte maturation medium on subsequent mouse embryo development

  • Byung Chul Jee, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, South Korea
    • Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada
    • ,
  • Hai-Ying Chen, B.Sc.

      Affiliations

    • Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada
    • ,
  • Ri-Cheng Chian, Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Ri-Cheng Chian, Ph.D., Department of Obstetrics and Gynecology, Royal Victoria Hospital, Women's Pavilion F3-46, 687 Pine Avenue West, Montreal, Quebec H31 1A1, Canada (FAX: 514-843-1662).

Received 13 February 2008 ,Revised 12 March 2008 ,Accepted 13 March 2008.

References 

  1. Chian RC, Lim JH, Tan SL. State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol. 2004;16:211–219
  2. Jurema MW, Nogueira D. In vitro maturation of human oocytes for assisted reproduction. Fertil Steril. 2006;86:1277–1291
  3. Eppig JJ, Schultz RM, O'Brien M, Chesnel F. Relationship between the developmental programs controlling nuclear and cytoplasmic maturation of mouse oocytes. Dev Biol. 1994;164:1–9
  4. Anderiesz C, Fong CY, Bongso A, Trounson AO. Regulation of human and mouse oocyte maturation in vitro with 6-dimethylaminopurine. Hum Reprod. 2000;15:379–388
  5. Sirard MA. Resumption of meiosis: mechanism involved in meiotic progression and its relation with developmental competence. Theriogenology. 2001;55:1241–1254
  6. Faerge I, Mayes M, Hyttel P, Sirard MA. Nuclear ultrastructure in bovine oocytes after inhibition of meiosis by chemical and biological inhibitors. Mol Reprod Dev. 2001;59:459–467
  7. Guixue Z, Luciano AM, Coenen K, Gandolfi F, Sirard MA. The influence of cAMP before or during bovine oocyte maturation on embryonic developmental competence. Theriogenology. 2001;55:1733–1743
  8. Wu GM, Sun QY, Mao J, Lai L, McCauley TC, Park KW, et al. High developmental competence of pig oocytes after meiotic inhibition with a specific m-phase promoting factor kinase inhibitor, butyrolactone I. Biol Reprod. 2002;67:170–177
  9. Le Beux G, Richard FJ, Sirard MA. Effect of cycloheximide, 6-DMAP, roscovitine and butyrolactone I on resumption of meiosis in porcine oocytes. Theriogenology. 2003;60:1049–1058
  10. Shimada M, Nishibori M, Isobe N, Kawano N, Terada T. Luteinizing hormone receptor formation in cumulus cells surrounding porcine oocytes and its role during meiotic maturation of porcine oocytes. Biol Reprod. 2003;68:1142–1149
  11. Tsafriri A, Chun SY, Zhang R, Hsueh AJ, Conti M. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev Biol. 1996;178:393–402
  12. Conti M, Anderson CB, Richard FJ, Shitsukawa K, Tsafriri A. Role of cyclic nucleotide phosphodiesterases in resumption of meiosis. Mol Cell Endocrinol. 1998;145:9–14
  13. Richard FJ. Regulation of meiotic maturation. J Anim Sci. 2007;85(13 Suppl):4–6
  14. Wiersma A, Hirsch B, Tsafriri A, Hanssen RG, Van de Kant M, Kloosterboer HJ, et al. Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents. J Clin Invest. 1998;102:532–537
  15. Coticchio G, Rossi G, Borini A, Grøndahl C, Macchiarelli G, Flamigni C, et al. Mouse oocyte meiotic resumption and polar body extrusion in vitro are differentially influenced by FSH, epidermal growth factor and meiosis-activating sterol. Hum Reprod. 2004;19:2913–2918
  16. Mayes MA, Sirard MA. Effect of type 3 and type 4 phosphodiesterase inhibitors on the maintenance of bovine oocytes in meiotic arrest. Biol Reprod. 2002;66:180–184
  17. Thomas RE, Armstrong DT, Gilchrist RB. Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation. Dev Biol. 2002;244:215–225
  18. Jensen JT, Schwinof KM, Zelinski-Wooten MB, Conti M, DePaolo LV, Stouffer RL. Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro. Hum Reprod. 2002;17:2079–2084
  19. Nogueira D, Albano C, Adriaenssens T, Cortvrindt R, Bourgain C, Devroey P, et al. Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro. Biol Reprod. 2003;69:1042–1052
  20. Nogueira D, Cortvrindt R, De Matos DG, Vanhoutte L, Smitz J. Effect of phosphodiesterase type 3 inhibitor on developmental competence of immature mouse oocytes in vitro. Biol Reprod. 2003;69:2045–2052
  21. Thomas RE, Thompson JG, Armstrong DT, Gilchrist RB. Effect of specific phosphodiesterase isoenzyme inhibitors during in-vitro maturation of bovine oocytes on meiotic and developmental capacity. Biol Reprod. 2004;71:1142–1149
  22. Nogueira D, Ron-El R, Friedler S, Schachter M, Raziel A, Cortvrindt R, et al. Meiotic arrest in vitro by phosphodiesterase 3-inhibitor enhances maturation capacity of human oocytes and allows subsequent embryonic development. Biol Reprod. 2006;74:177–184
  23. Vanhoutte L, De Sutter P, Nogueira D, Gerris J, Dhont M, Van der Elst J. Nuclear and cytoplasmic maturation of in vitro matured human oocytes after temporary nuclear arrest by phosphodiesterase 3-inhibitor. Hum Reprod. 2007;22:1239–1246
  24. Van Blerkom J. Maturation at high frequency of germinal-vesicle-stage mouse oocytes after cryopreservation: alterations in cytoplasmic, nuclear, nucleolar and chromosomal structure and organization associated with vitrification. Hum Reprod. 1989;4:883–898
  25. Sun QY, Lai L, Bonk A, Prather RS, Schatten H. Cytoplasmic changes in relation to nuclear maturation and early embryo developmental potential of porcine oocytes: effects of gonadotropins, cumulus cells, follicular size, and protein synthesis inhibition. Mol Reprod Dev. 2001;59:192–198
  26. Ola SI, Wang Q, Ai JS, Yin S, Liang CG, Chen DY, et al. Meiotic competence and acetylation pattern of UV light classified mouse antral oocytes after meiotic arrest with isobutylmethylxanthine. Mol Reprod Dev. 2007;74:591–599
  27. Bouniol-Baly C, Hamraoui L, Hamraoui L, Guibert J, Beaujean N, Szollosi MS, et al. Differential transcriptional activity associated with chromatin configuration in fully-grown mouse germinal vesicle oocytes. Biol Reprod. 1999;60:580–587
  28. Zuccotti M, Rossi PG, Martinez A, Garagna S, Forabosco A, Redi CA. Meiotic and developmental competence of mouse antral oocytes. Biol Reprod. 1998;58:700–704
  29. De La Fuente R, Eppig JJ. Transcriptional activity of the mouse oocytes genome: companion granulosa cells modulate transcription and chromatin remodeling. Dev Biol. 2001;229:224–236
  30. Vanhoutte L, Nogueira D, Gerris J, Dhont M, De Sutter P. Effect of temporary nuclear arrest by phosphodiesterase 3-inhibitor on morphological and functional aspects of in vitro matured mouse oocytes Mol. Reprod Dev. In press.
  31. Lonergan P, Fair T, Khatir H, Cesaroni G, Mermillod P. Effect of protein synthesis inhibition before or during in vitro maturation on subsequent development of bovine oocytes. Theriogenology. 1998;50:417–431
  32. Duque P, Díez C, Royo L, Lorenzo PL, Carneiro G, Hidalgo CO, et al. Enhancement of developmental capacity of meiotically inhibited bovine oocytes by retinoic acid. Hum Reprod. 2002;17:2706–2714
  33. Hashimoto S, Minami N, Takakura R, Imai H. Bovine immature oocytes acquire developmental competence during meiotic arrest in vitro. Biol Reprod. 2002;66:1696–1701
  34. Somfai T, Kikuchi K, Onishi A, Iwamoto M, Fuchimoto D, Papp AB, et al. Meiotic arrest maintained by cAMP during the initiation of maturation enhances meiotic potential and developmental competence and reduces polyspermy of IVM/IVF porcine oocytes. Zygote. 2003;11:199–206
  35. Albarracín JL, Morató R, Izquierdo D, Mogas T. Effects of roscovitine on the nuclear and cytoskeletal components of calf oocytes and their subsequent development. Theriogenology. 2005;64:1740–1755

 B.C.J. has nothing to disclose. H.Y.C. has nothing to disclose. R.-C.C. has nothing to disclose.

PII: S0015-0282(08)00708-5

doi: 10.1016/j.fertnstert.2008.03.041

Fertility and Sterility
Volume 91, Issue 5, Supplement , Pages 2037-2042 , May 2009

Article Tools

* Image Usage & Resolution